1. Carroll KM, Onken LS. Behavioral therapies for drug abuse. Am J Psychiatry. 2005;162:1452–60. [PMC free article] [PubMed] 2. Griffith JD, Rowan-Szal GA, Roark RR, Simpson DD. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depend. 2000;58:55–66. [PubMed] 3. Stanton MD, Shadish WR. Outcome, attrition, and family-couples treatment for drug abuse: a meta-analysis and review of the controlled, comparative studies. Psychol Bull. 1997;122:170–91. [PubMed] 4. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003;71:843–61. [PubMed] 5. Irvin JE, Bowers CA, Dunn ME, Wong MC. Efficacy of relapse prevention: a meta-analytic review. J Consult Clin Psychol. 1999;67:563–70. [PubMed]
6. Nathan PE, Gorman JM. A Guide to Treatments That Work. 2. New York: Oxford University Press; 2002.
7. Chambless DL, Ollendick TH. Empirically supported psychological interventions: controversies evidence. Annu Rev Psychol. 2001;52:685–716. [PubMed]
8. Roth A, Fonagy P. What Works for Whom? a Critical Review of the Psychotherapy Literature. 2. New York: Guilford Press; 2005.
9. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-Based Medicine. New York: Churchill Livingstone; 1997.
10. Chambless DL, Hollon SD. Defining empirically supported therapies. J Consult Clin Psychol. 1998;66:7–18. [PubMed] 11. Beutler LE. David and Goliath: when empirical and clinical standards of practice meet. Am Psychol. 2000;55:997–1007. [PubMed] 12. Sanderson WC. Why empirically supported psychological treatments are important. Behav Modif. 2003;27:290–9. [PubMed] 13. Follette WC, Beitz K. Adding a more rigorous scientific agenda to the empirically supported treatment movement. Behav Modif. 2003;27:369–86. [PubMed] 14. Rosen GM, Davidson GC. Psychology should list empirically suported principles of change (ESPs) and not credential trademarked therapies or other treatment packages. Behav Modif. 2003;27:300–12. [PubMed] 15. Westen D, Novotney CM, Thompson-Brenner H. The empirical status of empirically supported psychotherapies: assumptions, findings, and reporting in controlled clinical trials. Psychol Bull. 2004;130:631–63. [PubMed]
16. Garfield SL. Some problems associated with ‘validated’ forms of therapy. Clin Psychol Sci Pract. 1996;3:218–29.
17. Wampold BE, Bhati KS. Attending to the omissions: a historical examination of evidence-based practice movements. Profess Psychol Res Pract. 2004;35:563–70.
18. Herbert JD. The science and practice of empirically supported treatments. Behav Modif. 2003;27:412–30. [PubMed]
19. Institute of Medicine. Bridging the Gap Between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment. Washington, DC: National Academy Press; 1998.
20. Institute of Medicine. Crossing the Quality Chasm: a New Mental Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
21. Fals-Stewart W, Logsdon T, Birchler GR. Diffusion of an empirically supported treatment for substance abuse: an organizational autopsy of technology transfer success and failure. Clin Psychol Sci Pract. 2004;11:177–82.
22. McLellan AT, McKay JR. The treatment of addiction: what can research offer practice? In: Lamb S, Greenlick MR, McCarty D, editors. Bridging the gap between practice and research: forging partnerships with community based drug and alcohol treatment. Washington, DC: National Academy Press; 1998. pp. 147–85.
23. Margolin A, Kleber HD, Avants SK, et al. Acupuncture for the treatment of cocaine addiction: a randomized controlled trial. JAMA. 2002;287:55–63. [PubMed] 24. Dishion TJ, McCord J, Poulin F. When interventions harm: peer groups and problem behavior. Am Psychol. 1999;54:755–64. [PubMed] 25. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2003;2:CD002209. [PubMed] 26. Masson CL, Barnett PG, Sees KL, Delucchi KL, Rosen A, Wong W, et al. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification. Addiction. 2004;99:718–26. [PubMed] 27. McLellan AT, Carise D, Kleber HD. Can the national addiction treatment infrastructure support the public’s demand for quality care? J Subst Abuse Treat. 2003;25:117–21. [PubMed] 28. Babor TF, Higgins-Biddle JC. Alcohol screening and brief intervention: dissemination strategies for medical practice and public health. Addiction. 2000;95:677–86. [PubMed]
29. Lambert ME, Whipple JL, Vermeersch DA, Nielsen SL, Smart DW. Is it time for clinicians to routinely track patient outcome? A meta-analysis. Clin Psychol Sci Pract. 2003;10:288–301.
30. Luborsky L, Rosenthal R, Diguer L, Andrusyna TP, Berman JS, Levitt JT, et al. The dodo bird verdict is alive and well—mostly. Clin Psychol Sci Pract. 2002;9:2–12.
31. Luborsky L, Singer B, Luborsky L. Comparative studies of psychotherapies: is it true that ‘Everyone has won all must have prizes’? Arch Gen Psychiatry. 1975;32:995–1008. [PubMed] 32. Project MATCH Research Group. Matching alcohol treatments to client heterogeneity: Project MATCH posttreatment drinking. J Stud Alcohol. 1997;58:7–29. [PubMed] 33. UK Alcohol Treatment Trial (UKATT) Research Team. Effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT) BMJ. 2005;331:541. [PMC free article] [PubMed] 34. Morgenstern J, Blanchard KA, Morgan TJ, Labouvie E, Hayaki J. Testing the effectiveness of cognitive-behavioral treatment for substance abuse in a community setting: within treatment and posttreatment findings. J Consult Clin Psychol. 2001;69:1007–17. [PubMed]
35. Addis ME, Waltz J. Implicit and untested assumptions aout the role of psychotherapy treatment manuals in evidence-based mental health practice. Clin Psychol Sci Pract. 2002;9:421–4.
36. Shadish WR, Matt GE, Navarro AM, Siegle G, Crits-Christoph P, Hazelrigg MD, et al. Evidence that therapy works in clinically representative conditions. J Consult Clin Psychol. 1997;65:355–65. [PubMed] 37. Weisz JR, Jensen-Doss A, Hawley KM. Evidence-based youth psychotherapies versus usual clinical care. Am Psychol. 2006;61:671–89. [PubMed]
38. Addis ME. Methods for disseminating research products and increasing evidence-based practice: promises, obstacles, and future directions. Clin Psychol Sci Pract. 2002;9:367–78.
39. Hanson GR, Leshner AI, Tai B. Putting drug abuse research to work in real-life settings. J Subst Abuse Treat. 2002;23:69–70. [PubMed] 40. Carroll KM, Rounsaville BJ. Bridging the gap between research and practice in substance abuse treatment: a hybrid model linking efficacy and effectiveness research. Psychiatr Serv. 2003;54:333–9. [PMC free article] [PubMed] 41. Peirce JM, Petry NM, Stitzer ML, Blaine JD, Kellog S, Satterfield F, et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry. 2006;63:201–8. [PubMed] 42. Petry NM, Peirce JM, Stitzer ML, Blaine JD, Roll JM, Cohen A, et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse Clinical Trials Network study. Arch Gen Psychiatry. 2005;62:1148–56. [PubMed] 43. Carroll KM, Ball SA, Nich C, Martino S, Frankforter T, Farentinos C, et al. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend. 2006;81:301–12. [PMC free article] [PubMed] 44. Ball SA, Martino S, Nich C, Frankforter TL, Van Horn DH, Crits-Christoph P, et al. Site matters: motivational enhancement therapy in community drug abuse clinics. J Consult Clin Psychol. in press. [PMC free article] [PubMed] 45. Ling W, Amass L, Shoptaw S, Annon JJ, Hillhouse M, Babcock D, et al. 2005 A multicenter randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction. 2006;100:1090–100. [PMC free article] [PubMed] 46. Carroll KM, Farentinos C, Ball SA, Crits-Christoph P, Libby B, Morgenstern J, et al. MET meets the real world: design issues and clinical strategies in the Clinical Trials Network. J Subst Abuse Treat. 2002;23:73–80. [PMC free article] [PubMed] 47. Collins LM, Murphy SA, Bierman KL. A conceptual framework for adaptive preventive interventions. Prev Sci. 2004;5:185–96. [PMC free article] [PubMed] 48. Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, et al. Bupropion-SR, sertra-line, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006;354:1231–42. [PubMed] 49. Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, et al. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials. 2004;25:119–42. [PubMed] 50. Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354:1243–52. [PubMed] 51. Murphy SA, Lynch KG, Oslin D, McKay JR, Tenhave T. Developing adaptive treatment strategies in substance abuse research. Drug Alcohol Depend. 2007;88(Suppl 2):S24–S39. [PMC free article] [PubMed] 52. O’Malley SS, Rounsaville BJ, Farren C, Namkoong K, Wu R, Robinson J, et al. Initial and maintenance naltrex-one treatment for alcohol dependence using primary care vs. specialty care: a nested sequence of three randomized trials. Arch Intern Med. 2003;163:1695–704. [PubMed]
53. Onken LS, Blaine JD, Battjes R. Behavioral therapy research: a conceptualization of a process. In: Hennegler SW, Amentos R, editors. Innovative approaches for difficult to treat populations. Washington, DC: American Psychiatric Press; 1997. pp. 477–85.
54. Rounsaville BJ, Carroll KM, Onken LS. A stage model of behavioral therapies research: getting started and moving on from Stage I. Clin Psychol Sci Pract. 2001;8:133–42.
55. Hohmann AA, Shear MK. Community-based intervention research: coping with the ‘noise’ of real life in study design. Am J Psychiatry. 2002;159:202–7. [PubMed] 56. Miller WR, Wilbourne PL. Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction. 2002;97:265–77. [PubMed] 57. MTP Research Group. Brief treatments for cannabis dependence: findings from a randomized multisite trial. J Consult Clin Psychol. 2004;72:455–66. [PubMed] 58. Carroll KM, Easton CJ, Nich C, Hunkele KA, Neavins TM, Sinha R, et al. The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. J Consult Clin Psychol. 2006;74:955–66. [PMC free article] [PubMed] 59. Anton RF, O’Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295:2003–17. [PubMed] 60. Olmstead T, Sindelar JL, Easton CJ, Carroll KM. The cost-effectiveness of four treatments for marijuana dependence. Addiction. in press. [PMC free article] [PubMed] 61. Weissman MM, Verdeli H, Gameroff MJ, Bledsoe SE, Betts K, Mufson L, et al. National survey of psychotherapy training in psychiatry, psychology, and social work. Arch Gen Psychiatry. 2006;63:925–34. [PubMed]
62. Crits-Christoph P, Frank E, Chambless DL, Brody C, Karp JF. Training in empirically validated therapies: what are clinical psychology students learning? Profess Psychol Res Pract. 1995;26:514–22.
63. Davis DA, Thomson MA, Oxman AD, Haynes RB. Evidence for the effectiveness of CME: a review of 50 randomized controlled trials. JAMA. 1992;268:1111–17. [PubMed]
64. Gotham HJ. Diffusion of mental health and substance abuse treatments: development, dissemination, and implementation. Clin Psychol Sci Pract. 2004;11:160–76.
65. VandeCreek L, Knapp S, Brace K. Mandatory continuing education for licensed psychologists: its rationale and current implications. Profess Psychol Res Pract. 1990;21:135–40.
66. Barlow DH, Levitt JT, Bufka LF. The dissemination of empirically supported treatments: a view to the future. Behav Res Ther. 1999;37:S147–62. [PubMed] 67. Miller WR, Yahne CE, Moyers TB, Martinez J, Pirritano M. A randomized trial of methods to help clinicians learn motivation interviewing. J Consult Clin Psychol. 2004;72:1050–62. [PubMed]
68. Rubel EC, Sobell LC, Miller WR. Do continuing workshops improve participants skills? Effects of a motivational interviewing workshop on substance-abuse counselors’ skills and knowledge. Behav Ther. 2000;23:73–7.
69. Sholomskas D, Syracuse G, Ball SA, Nuro KF, Rounsaville BJ, Carroll KM. We don’t train in vain: a dissemination trial of three strategies for training clinicians in cognitive behavioral therapy. J Consult Clin Psychol. 2005;73 :106–15. [PMC free article] [PubMed] 70. Crits-Christoph P, Siqueland L, Chittams J, Barber JP, Beck AT, Frank A, et al. Training in cognitive, supportive-expressive, and drug counseling therapies for cocaine dependence. J Consult Clin Psychol. 1998;66:484–92. [PubMed] 71. Weissman MM, Rounsaville BJ, Chevron E. Training psychotherapists to participate in psychotherapy outcome studies. Am J Psychiatry. 1982;139:1442–6. [PubMed] 72. Carroll KM, Connors GJ, Cooney NL, DiClemente CC, Donovan DM, Longabaugh RL, et al. Internal validity of Project MATCH treatments: discriminability and integrity. J Consult Clin Psychol. 1998;66:290–303. [PubMed] 73. Vakoch DA, Strupp HH. The evolution of psychotherapy training: reflections on manual-based learning and future activities. J Clin Psychol. 2000;56:309–18. [PubMed] 74. Miller WR, Moyers TB, Arciniega L, Ernst D, Force-himes A. Training, supervision and quality monitoring of the COMBINE Study behavioral interventions. J Stud Alcohol. 2005;15(Suppl):188–95. discussion 168–9. [PubMed] 75. Tober G, Godfrey C, Parrott S, Copello A, Farrin A, Hodgson R, et al. Setting standards for training and competence: the UK alcohol treatment trial. Alcohol Alcohol. 2005;40:413–8. [PubMed] 76. Carroll KM, Kadden R, Donovan D, Zweben A, Roun-saville BJ. Implementing treatment and protecting the validity of the independent variable in treatment matching studies. J Stud Alcohol. 1994;(Suppl 12):149–55. [PubMed] 77. Baer JS, Ball SA, Campbell BK, Miele GM, Schoener EP, Tracy K. Training and fidelity monitoring of behavioral interventions in multi-site addictions research. Drug Alcohol Depend. 2007;87:107–18. [PMC free article] [PubMed] 78. Andrzejewski ME, Kirby KC, Morral AR, Iguchi MY. Technology transfer through performance management: the effects of graphical feedback and positive reinforcement on drug treatment counselors’ behavior. Drug Alcohol Depend. 2001;63:179–86. [PubMed] 79. Martin GW, Herie MA, Turner BJ, Cunningham JA. A social marketing model for disseminating research-based treatments to addictions treatment providers. Addiction. 1998;93:1703–15. [PubMed] 80. Henggeler SW, Schoenwald SK, Liao JG, Letourneau EJ, Edwards DL. Transporting efficacious treatments to field settings: the link between supervisory practices and therapist fidelity in MST programs. J Clin Child Adolesc Psychol. 2002;31:155–67. [PubMed] 81. Carroll KM, Nich C, Sifry R, Nuro KF, Frankforter T, Ball SA, et al. A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug Alcohol Depend. 2000;57:225–38. [PubMed] 82. Waltz J, Addis ME, Koerner K, Jacobson NS. Testing the integrity of a psychotherapy protocol: assessment of adherence and competence. J Consult Clin Psychol. 1993;61 :620–30. [PubMed] 83. Calhoun KS, Moras K, Pilkonis PA, Rehm LP. Empirically supported treatments: implications for training. J Consult Clin Psychol. 1998;66:151–62. [PubMed] 84. McLellan AT, Carise D, Kleber HD. Can the national addiction treatment infrastructure support the public’s demand for quality care? J Subst Abuse Treat. 2003;25:117–21. [PubMed]
85. McLellan AT. What we need is a system: creating a responsive and effective substance abuse treatment system. In: Miller WR, Carroll KM, editors. Rethinking substance abuse: what the science shows and what we should do about it. New York: Guilford Press; 2006. pp. 275–92.
86. Olmstead TA, Sindelar JL, Petry NM. Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug Alcohol Depend. 2007;87:175–82. [PMC free article] [PubMed]
87. Chiles JA, Lambert ME, Hatch AL. The impact of psychological interventions on medical cost offset: a meta-analytic review. Clin Psychol Sci Pract. 1999;6:204–20.
88. Yates BT. Toward the incorporation of costs, cost-effectiveness analysis, and cost–benefit analysis into clinical research. J Consult Clin Psychol. 1994;62:729–36. [PubMed] 89. Addis ME, Krasnow AD. A national survey of practicing psychologists’ attitudes toward psychotherapy treatment manuals. J Consult Clin Psychol. 2000;68:430–41. [PubMed]
90. Prochaska JO, DiClemente CC. Transtheoretical therapy: toward a more integrative model of change. Psychother Theory Res Pract. 1982;19:276–88.
91. Beutler LE, Moleiro C, Talebi H. How practitioners can systematically use empirical evidence in treatment selection. J Clin Psychol. 2002;58:1199–212. [PubMed] 92. Kazdin AE, Nock MK. Delineating mechanisms of change in child and adolescent therapy: methodological issues and research recommendations. J Child Psychol Psychiatry. 2003;44:1116–29. [PubMed] 93. O’Donohue W, Yeater EA. Individuating psychotherapies. Behav Modif. 2003;27:313–21. [PubMed]
94. Haaga DAF. Being systematic, and maybe even scientific, about planning psychotherapy research. Clin Psychol Sci Pract. 2004;11:387–0.
95. O’Donohue W, Buchanan JA, Fisher JE. Characteristics of empirically supported treatments. J Psychother Pract Res. 2000;9:69–74. [PMC free article] [PubMed]
96. Beutler LE, Clarkin JF, Bongar BM. Guidelines for the Systematic Treatment of Depressed Patients. New York: Oxford University Press; 2000.
97. Beutler LE, Harwood HJ. Prescriptive Psychotherapy: a Practical Guide to Systematic Treatment Selections. New York: Oxford University Press; 2000.
98. Ball SA, Bachrach K, DeCarlo J, Farentinos C, Keen M, McSherry T, et al. Characteristics of community clinicians trained to provide manual-guided therapy for substance abusers. J Subst Abuse Treat. 2002;23:309–18. [PubMed] 99. Berwick DM. Disseminating innovations in health care. JAMA. 2003;289:1969–75. [PubMed]
100. Wiltsey Stirman S, Crits-Christoph P, DeRubeis RJ. Achieving successful dissemination of empirically supported therapies: a synthesis of dissemination theory. Clin Psychol Sci Pract. 2004;11:343–59.
101. Petry NM. A comprehensive guide to the application of contigency management procedures in clinical settings. Drug Alcohol Depend. 2000;58:9–25. [PubMed] 102. Kirby KC, Marlowe DB, Festinger DS, Lamb RJ, Platt JJ. Schedule of voucher delivery influences initiation of cocaine abstinence. J Consult Clin Psychol. 1998;66:761–7. [PubMed] 103. DeRubeis RJ, Crits-Christoph P. Empirically supported individual and group psychological treatments for adult mental disorders. J Consult Clin Psychol. 1998;66:37–52. [PubMed] 104. Weissman MM, Markowitz JC. Interpersonal psychotherapy. current status. Arch Gen Psychiatry. 1994;51:599–606. [PubMed] 105. Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract. 2005;55:305–12. [PMC free article] [PubMed] 106. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003;71:843–61. [PubMed] 107. Henggeler SW, Melton GB, Brondino MJ, Scherer DG, Hanley JH. Multisystemic therapy with violent and chronic juvenile offenders and their families: the role of treatment fidelity. J Consult Clin Psychol. 1997;65:821–33. [PubMed] 108. Foley SH, O’Malley SS, Rounsaville BJ. The relationship between patient difficulty and therapist performance in interpersonal psychotherapy. J Affect Disord. 1987;12:207–17. [PubMed] 109. Barber JG, Crits-Christoph P, Luborsky L. Effects of therapist adherence and competence on patient outcome in brief dynamic therapy. J Consult Clin Psychol. 1996;64:619–22. [PubMed] 110. Henry WP, Strupp HH, Butler SF, Schacht TE, Binder JL. Effects of training in time-limited dynamic psychotherapy: changes in therapist behavior. J Consult Clin Psychol. 1993;61:434–40. [PubMed] 111. Castonguay LG, Goldfried MR, Wiser S, Raue PJ, Hayes AM. Predicting the effect of cognitive therapy for depression: a study of unique and common factors. J Consult Clin Psychol. 1996;64:497–504. [PubMed] 112. Sholomskas DE, Carroll KM. One small step for manuals: computer-assisted training in twelve-step facilitation. J Stud Alcohol. 2006;67:939–45. [PMC free article] [PubMed] 113. Issenberg SB, McGaghie WC, Hart IR, Mayer JW, Felner JM, Petrusa ER, et al. Simulation technology for health care professional skills training and assessment. JAMA. 1999;282:861–6. [PubMed] 114. Todd KH, Braslow A, Brennan RT, Lowery DW, Cox RJ, Lipscomb LE, et al. Randomized, controlled trial of video self-instruction versus traditional CPR training. Ann Emerg Med. 1998;31:364–9. [PubMed] 115. Huang MP, Alessi NE. The internet and the future of psychiatry. Am J Psychiatry. 1996;153:861–9. [PubMed] 116. Piemme TE. Computer-assisted learning and evaluation in medicine. JAMA. 1988;260:367–72. [PubMed]
117. Jones I, Cookson J. Computer-assisted learning design for reflective practice supporting multiple learning styles for education and training in pre-hospital emergency care. Int J Train Dev. 2001;5:74–80.
118. Budman SH. Computer-mediated addiction services: tomorrow won’t look like today. Behav Healthcare Tomorrow. 2002;11:14–21. [PubMed] 119. Davis DD, Thompson O’Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education. JAMA. 1999;282:867–74. [PubMed] 120. Williams CD, Aubin S, Harkin P, Cottrell D. A randomized, controlled, single-blind trial of teaching provided by a computer-based multimedia package versus lecture. Med Educ. 2001;35:847–54. [PubMed] 121. Carise D, McLellan AT, Gifford LS, Kleber HD. 1999 Developing a national addiction treatment information system: an introduction to the Drug Evaluation Network System. J Subst Abuse Treat. 2002;17:67–77. [PubMed]
122. McLellan AT, Belding MA, McKay JR, Zanis D, Alterman AI. Can the outcomes research literature inform the search for quality indicators in substance abuse treatment? In: Edmunds M, Frank RG, Hogan M, McCarty D, Robinson-Beale R, Weisner C, editors. Managing managed care: quality improvement in behavioral health. Washington, DC: National Academy Press; 1996.
123. Keane DR, Norman GR, Vickers J. The inadequacy of recent research on computer-assisted instruction. Acad Med. 1991;66:44–8. [PubMed] 124. Clark RE. Dangers in evaluation of instructional media. Acad Med. 1992;12:819–20. [PubMed] 125. Vogel M, Wood DF. Love it or hate it? Medical students’ attitudes to computer-assisted learning. Med Educ. 2002;36 :214–15. [PubMed] 126. Cook DA. Learning and cognitive styles in web-based learning: theory, evidence, and application. Acad Med. 2005;80:266–78. [PubMed]
127. Lane JM, Addis ME. Pros and cons of educational technology as methods for disseminating evidence-based treatments. Clin Psychol Sci Pract. 2004;11:336–8.
128. Crits-Christoph P, Baranackie K, Kurcias J, Beck AT, Carroll KM, Perry K, et al. Meta-analysis of therapist effects in psychotherapy outcome studies. Psychother Res. 1991;1:81–91.
129. Carroll KM. Constrained, confounded, and confused: why we know so little about therapist effects. Addiction. 2001;96 :203–6. [PubMed]
130. Project MATCH Research Group. Therapist effects in three treatments for alcohol problems. Psychother Res. 1998;8:455–74.
131. Budman SH. Behavioral health care dot-com and beyond: computer-mediated communications in mental health and substance abuse treatment. Am Psychol. 2000;55:1290–300. [PubMed]
132. Marks I, Shaw S, Parkin R. Computer-aided treatments of mental health problems. Clin Psychol Sci Pract. 1998;5:151–70.
133. Norquist G, Regier DA. The epidemiology of psychiatric disorders and the de facto mental health care system. Annu Rev Med. 1996;47:473–9. [PubMed] 134. Kirkby KC. Computer-assisted treatment of phobias. Psychiatr Serv. 1996;47:139–40. [PubMed] 135. Baer L, Greist JH. An interactive computer-administered self-assessment and self-help program for behavior therapy. J Clin Psychiatry. 1997;58:23–8. [PubMed] 136. Newman MG, Kenardy J, Herman S, Taylor CB. Comparison of palmtop-computer assisted brief cognitive-behavioral treatment to cognitive-behavioral treatment for panic disorder. J Consult Clin Psychol. 1997;65:178–83. [PubMed] 137. Wright JH, Wright AS, Albano AM, Basco MR, Goldsmith LJ, Raffield T, et al. Computer-assisted cognitive therapy for depression: maintaining efficacy while reducing therapist time. Am J Psychiatry. 2005;162:1158–64. [PubMed] 138. Selmi PM, Klein MH, Greist JH, Sorrell SP, Erdman HP. Computer-administered CBT for depression. Am J Psychiatry. 1990;147:51–6. [PubMed] 139. Slate SE, Meyer TL, Burns WJ, Montgomery DD. Computerized cognitive training for severely emotionally disturbed children with ADHD. Behav Modif. 1998;22:415–20. [PubMed] 140. Shiffman S, Paty JA, Rohay JM, DiMarino ME, Gitchell JG. The efficacy of computer-tailored smoking cessation material as a supplement to nicotine patch therapy. Drug Alcohol Depend. 2001;64:35–46. [PubMed]
141. Carroll KM. A Cognitive-Behavioral Approach: Treating Cocaine Addiction. Rockville, MD: NIDA;
142. Paul GL. 1967 Strategy of outcome research in psychotherapy. J Clin Psychol. 1998;31:109–18. [PubMed] 143. Paul GL, Licht MH. Resurrection of the uniformity assumption myth and the fallacy of statistical absolutes in psychotherapy research. J Consult Clin Psychol. 1978;46:1531–4. [PubMed]